DALLAS, June 23, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on manufacturing and marketing ...
A recent study published in Canadian Journal of Health Technologies examined the effectiveness of using metered-dose inhalers (MDIs) for medical cannabis and the evidence based guidelines for MDI use.
LONDON, June 04, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces the initiation of a ...
LONDON, March 31, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces positive ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...
March 14, 2006 — The US Food and Drug Administration (FDA) has approved a pressurized metered-dose inhaler (pMDI) formulation of flunisolide for the maintenance treatment of asthma in patients aged 6 ...
Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...
Pulmonary administration exploits the large surface area and thin epithelial barrier of the lung to achieve both local and systemic therapy with rapid onset. Delivery platforms include nebulisers, ...
Switching from a metered dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results